Vivos Therapeuticsinc Stock Total Debt
| VVOS Stock | USD 2.66 0.04 1.48% |
Vivos TherapeuticsInc fundamentals help investors to digest information that contributes to Vivos TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Vivos Stock. The fundamental analysis module provides a way to measure Vivos TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivos TherapeuticsInc stock.
Total Debt To Capitalization is likely to gain to 1.14 in 2024. Vivos | Total Debt |
Vivos TherapeuticsInc Company Total Debt Analysis
Vivos TherapeuticsInc's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Vivos TherapeuticsInc Total Debt | 2 M |
Most of Vivos TherapeuticsInc's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vivos TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vivos Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Vivos TherapeuticsInc is extremely important. It helps to project a fair market value of Vivos Stock properly, considering its historical fundamentals such as Total Debt. Since Vivos TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vivos TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vivos TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Vivos Total Debt Historical Pattern
Today, most investors in Vivos TherapeuticsInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vivos TherapeuticsInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vivos TherapeuticsInc total debt as a starting point in their analysis.
Vivos TherapeuticsInc Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Vivos Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Vivos TherapeuticsInc has a Total Debt of 2 M. This is 99.93% lower than that of the Health Care Equipment & Supplies sector and 99.89% lower than that of the Health Care industry. The total debt for all United States stocks is 99.96% higher than that of the company.
Vivos Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vivos TherapeuticsInc's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vivos TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Vivos TherapeuticsInc by comparing valuation metrics of similar companies.Vivos TherapeuticsInc is currently under evaluation in total debt category among related companies.
Vivos TherapeuticsInc Institutional Holders
Institutional Holdings refers to the ownership stake in Vivos TherapeuticsInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vivos TherapeuticsInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vivos TherapeuticsInc's value.| Shares | Blackrock Inc | 2023-12-31 | 42.0 | Global Retirement Partners, Llc. | 2023-12-31 | 23.0 | Cutler Group Lp | 2023-12-31 | 12.0 | Steward Partners Investment Advisory, Llc | 2023-12-31 | 8.0 | Wells Fargo & Co | 2023-12-31 | 7.0 | Royal Bank Of Canada | 2023-12-31 | 7.0 | Apexium Financial, Lp | 2023-12-31 | 0.0 | Two Sigma Investments Llc | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-09-30 | 0.0 | Strategic Wealth Designers | 2023-12-31 | 128.8 K | Armistice Capital, Llc | 2023-12-31 | 57 K |
Vivos Fundamentals
| Return On Equity | -5.21 | ||||
| Return On Asset | -0.88 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (1.27) % | ||||
| Current Valuation | 7.73 M | ||||
| Shares Outstanding | 2.98 M | ||||
| Shares Owned By Insiders | 7.30 % | ||||
| Shares Owned By Institutions | 13.73 % | ||||
| Number Of Shares Shorted | 18.69 K | ||||
| Price To Book | 18.94 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 13.8 M | ||||
| Gross Profit | 12.6 M | ||||
| EBITDA | (16.68 M) | ||||
| Net Income | (13.58 M) | ||||
| Cash And Equivalents | 17.83 M | ||||
| Cash Per Share | 0.77 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 3.15 X | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (11.95 M) | ||||
| Short Ratio | 0.24 X | ||||
| Earnings Per Share | (11.14) X | ||||
| Target Price | 7.22 | ||||
| Number Of Employees | 114 | ||||
| Beta | 7.9 | ||||
| Market Capitalization | 8.05 M | ||||
| Total Asset | 10.73 M | ||||
| Retained Earnings | (93.05 M) | ||||
| Working Capital | (4.83 M) | ||||
| Net Asset | 10.73 M |
About Vivos TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivos TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vivos TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vivos TherapeuticsInc's short interest history, or implied volatility extrapolated from Vivos TherapeuticsInc options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports:Check out Vivos TherapeuticsInc Piotroski F Score and Vivos TherapeuticsInc Altman Z Score analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.